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Background: Rift Valley fever virus (RVFV) is a zoonotic arbovirus of public health impact infecting livestock,
wildlife, and humans mainly in Africa and other parts of the world. Despite its public health importance,
mechanisms of RVFV maintenance during inter-epidemic (IEPS) periods and potentially spread to new areas
remain unclear.We aimed to comparatively examine exposure to RVFV and RVFV infection among humans,
goats and mosquitoes in an agro-pastoral community in Lower Moshi area of Moshi rural district.
Results:Results show that the male gender was related to RVFV seropositivity (χ2 = 5.351; p=0.030). Being
50 years and above was related to seropositivity (χ2=14.430; p=0.006) whereas bed net use, larger numbers
of persons living in the same house (>7 persons) and RVFV seropositivity in goats were related to higher
seropositivity to RVFV among humans (χ2=6.003; p=0.021, χ2=23.213; p=0.000 and 27.053; p=0.000),
respectively.RVFV antibody concentrations were only marginally higher in humans without statistically
signi cant difference [t (112) =0.526; p=0.60)]. By the use of RT-qPCR, goats exhibited the highest RVFV
infection rate of 4.1%, followed by humans (2.6%), Aedes spp(2.3%), and Culex spp(1.5%).
Conclusions: In the absence of RVFV infection data in areas nearby the study site, our  ndings suggest
Lower Moshi area as a potential hotspot for RVF, posing the danger of being a source of RVFV spread to
other areas. Goats had the highest infection rate, suggesting goats as important hosts in the virus
maintenance during IEPs. We recommend the design and implementation of strategies that will warrant
effective active surveillance of RVF through the identi cation of RVF hotspots for targeted control of RVF.
Background
Rift Valley fever virus (RVFV) is a zoonotic arbovirus affecting livestock and humans mainly in Africa and
the Arabian Peninsula [1–4] although recent reports indicate the presence of RVF in other parts of the
world[5]. According to the World Health Organization (WHO), Rift Valley fever (RVF) is a priority disease due
to its considerable public health impact in areas where it occurs and the inadequate interventions to control
it [6]. It is also considered an important threat to agriculture in African countries including Tanzania [7–9].
Transmission of RVFV to animals is mainly through bites by infected Aedes and Culex mosquitoes, whereas
human transmission largely through direct contact with tissues of RVFV-infected animals[10].
It has been previously suggested that maintenance of the virus in animals during inter-epidemic (IEPS)
periods and potentially spread to new areas through animal movement. Disease pathology and endemic
maintenance within mammalian hosts have been reviewed [11, 12]. Although the transmission of RVFV by
mosquito vectors to animals and humans has been described, less is known about the role of animals,
humans, and vector mosquitoes in maintaining the virus during IEPS. The maintenance mechanisms during
IEPS become interesting due to the absence of a clear understanding of where the virus hides during the
"silent" periods. Some explanations have been made regarding the possible mechanisms by which the virus
is maintained during IEPS. Previous work has documented low-levels of RVFV exposure in northern, central,
eastern, and southern Tanzania as a key mechanism of virus maintenance [13, 14]. Most people infected by
RVFV remain asymptomatic although a small percentage present with clinical disease. Other reports have
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hypothesized critical mechanisms for survival of RVFV during long inter-epizootic periods as vertical
transmission through mosquito eggs to mosquito offspring[15–17].
Maintenance of RVFV depend on the presence of competent vectors and hosts but must coincide with
multiple factors such as su cient livestock density, rainfall providing vector breeding sites, and
temperatures that support vector development and pathogen replication [18], but differential exposure of
RVFV in high-risk agropastoral communities in Northern Tanzania has not been examined. We aimed to
comparatively examine exposure to RVFV and RVFV infection among humans, goats and mosquitoes in an
agropastoral community in Lower Moshi area of Moshi rural district.
Methods
Study Design and Site
A community-based, cross-sectional survey was conducted in three villages of lower Moshi in Moshi district,
Kilimanjaro region of Tanzania. Data were collected between March and June 2020 involving 3 villages,
namely Mikocheni, Chemchem, and Arusha Chini. Lower Moshi is located on the southern foothills of Mount
Kilimanjaro (Figure 1). On the west, Lower Moshi is bordered by the Kikuletwa River, Hai District, and
Manyara Region. To the east Lower Moshi borders Mwanga district. Lower Moshi elevation ranges between
700 and 800 m above sea level. The main Rift Valley Fever vectors in this area are Culex spp, Mansoniaspp,
Anopheles spp, and Aedes spp[19]. Numerous water streams cross the area and they form the irrigation
channels for rice and sugar cane. The rice irrigation schemes have structured and unstructured canal
networks; covering an area of about 1,100 hectares. During the rainy season, temporary pools that serve as
malaria vector breeding sites are formed. Their persistence beyond the rains contributes to further malaria
transmission. The area has two rainy seasons; the long rains which run from March to May and the short
rainy season from November to December. The average annual rainfall is about 900 mm per year[20].
Participants and sample collection
Participants in this study were males and females aged between 10 and 70 years, who were either
smallholder crop farmers or livestock keepers and willing to participate in this study. Animal sampling was
carried out by animal health experts from the Tanzania Veterinary Laboratory Agency (TVLA). Up to 15 goats
were selected from each herd by systematic sampling technique where every 3rdand 5th animal was included
depending on the size of the herd. Selected animals were manually restrained and 3 ml of blood collected
through jugular venipuncture using a vacutainer needle. Human blood sampling was done by expert
phlebotomists from the Kilimanjaro Christian Medical Center (KCMC). Three milliliters of blood were
collected from the median cubital vein by venipuncture. Each sample from both animals and humans was
divided into two aliquots of 1.5 ml each and placed into plain and EDTA vacutainer tubes, respectively. To
each sample in an EDTA tube, 4.5ml of Tri Reagent (Zymo Research, Irvine, CA, U.S.A.) were added. The
mixture was gently mixed by shaking for 1 minute and immediately shipped to the KCRI biotechnology
laboratory at 4°C, for analyses. Demographic data from participants were collected using electronic forms
designed using Open Data Kit (ODK)tools (https://opendatakit.org/) deployed in Android tablets.
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Mosquito trapping
BG Sentinel trap (BGS) (Biogents AG, Regensburg, Germany) to target outdoor host-seeking adult
mosquitoesparticularlyAedes spp, Ochlerotatusspp, Culex spp, Mansoniaspp, and Anopheles spp[21]. BGS
traps were used in combination with the BGS-Lure, a dispenser that releases emanations such as those
found on human skin (lactic acid, ammonia, and caproic acid)[22]. The BGS-Trap, developed by BioGents
GmbH (Regensburg, Germany), consists of an easy to transport, collapsible white bucket with white gauze
covering its opening. In the middle of the gauze cover, there is a black tube through which a down ow is
created by 12V DC fan that causes any mosquito in the vicinity of the opening tube sucked into a catch
bag[22]. Mosquitoes were immediately morphologically identi ed in the  eld and consequently sorted
according to species, sex, and whether fed or unfed.
Laboratory procedures
RVFV competitive ELISA (cELISA)
Serumwas extracted from the plain vacutainer tubes at the end of eachday by centrifugation of clotted blood
at3000 rpm for 5 min. An extracted serum sample was then transferred into 2 ml sterile cryovials using a
sterile Pasteur pipette. All serum samples were tested for the presence of antibodies against RVFV using a
competitive ELISA (cELISA)using the ID Screen RVFCompetition Multi-Species kit (ID-vet, Grables, France),
which detects both IgG and IgM antibodies directed against the RVFV nucleoprotein (NP). Validation tests
for the test kit have shown a sensitivity of between 91 and 100% and a speci city of 100%. The cELISA was
performed according to the instructions of the manufacturer and as described previously [23, 24]. To control
the validity of each plate, the mean value of the two negative controls (ODNC) was computed whereby a
plate was considered valid if the ODNC was>0.7. For a valid plate, the mean value of the two positive controls
divided by ODNC had to be <0.3. For each sample, the competition percentage was calculated by dividing
ODsample/ODNC) × 100. If the value was ≤0.4, the sample was considered positive while a value > 0.5 was
considered negative. Only samples that tested positive for cELISA were subjected to RT-qPCR for RVFV
detection.
Ribonucleic acid (RNA) isolation, puri cation, and real-time PCR ampli cation.
For detection of RVFV RNA in humans and goats, RNA was extracted from Trizol archived blood in EDTA
tubes using DirectZol miniprep kit (Zymo Research, Irvine, CA, U.S.A.) by using the Boom method. To isolate
RVFV RNA from mosquitoes, pools of 10-50 unfed monospeci c female mosquitoes were placed in cryovials
and transferred into Lysing Matrix, impact-resistant tubes containing 1.4 mm ceramic beads (MP
Biomedicals, CA, USA). Samples were disrupted by bead beating at 10,000 x g for 1min, spun at 1000 g for
10 min at 4°C. The supernatant was transferred into labeled RNase-free tubes. Puri cation procedures were
done using Direct-zol™ RNA miniprep kit (Irvine, CA, U.S.A) following the manufacturer's instructions.
For both human/goat and mosquito samples, RNA concentration and quality check were performed using
NanoDrop™ 2000 Spectrophotometer (Thermo Scienti c, NY, USA) before storage at -80°C. RVFV RNA was
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detected using TaqMan probe-based one-step RT-qPCR targeting the RVFV Gn gene as described by Gudo
and colleagues [2] using Applied Biosystems ViiA7 PCR platform, Thermo Scienti c, NY, USA).
Nature of data and data Analysis
Data analysis was performed using IBM SPSS v.26 (IBM® Corp., Armonk, NY, USA). Descriptive data were
presented as frequencies and percentages, means, and medians. Categorical data were reported as a
tabulation of proportions and compared between humans and goats. Chi-squared statistic (χ2) was used to
examine associations between seropositivity to RVFV and RVFV infection in both humans and goats. Mean
IgM and IgG concentrations were compared between humans and goats by paired t-test. Percent positivity to
RVFV infection in goats, humans, and mosquitoes were reported as histograms.
Ethical issues
This study obtained approval by the Kilimanjaro Christian Medical University College (KCMUCo) Research
and Ethics Committee (CRERC) with approval certi cate #2419. This study was also approved by the
Kilimanjaro Regional and District Administrative Secretaries, District Medical and Veterinary O cers, and
local village and ward executive o cers of respective villages. Before commencement of sample collection,
written informed consent was obtained from all study participants aged 18 years and above by signing
consent forms whereas parents and/or legal guardians of participants under 18 years and participants who
could not read or write consented on behalf. All authors hereby con rm that all procedures in this study were
approved by CRERC and were performed in accordance with the ethical standards as laid down in the 1964
Declaration of Helsinki. Authors also con rm that all procedures that involved animals in this study were
conducted in compliance with the ARRIVE guidelines.
Results
Demographic Characteristics of Human Participants
A total of 266 human participants were enrolled in the study. Of the participants, more than half (56.4%)
were females. The median age (interquartile range) of participants was 45 (30–55). The majority of
participants (74.4%) came from households with more than 4 persons in the same house. With regards to
the participant's education, 63.2% of participants had attained primary school education. Most participants
(72.9%) kept livestock (cattle, sheep, goats, and/or chicken). Three quarters (75.2%) of the participants
reported having used an insect side treated bed-net the night before the interview. (Table 1)
Page 6/15
Table 1
Demographic Characteristics of Participants
Characteristics n %








Individuals living in a household    
< 4 68 25.6
≥ 4 198 74.4
Highest education    
No formal 51 19.2
Primary 168 63.2
Tertiary 47 17.7
Type of animals kept by the participant    
Animal Keeping 194 72.9
None 72 27.1
Bed-net use*    
Yes 66 24.8
No 200 75.2
IQR, Interquartile Range; 72 missing entries*
Factors Associated With Rvfv Seropositivity In Humans And
Goats
Human RVFV seropositivity was analyzed for any associations with participant age, bed net use within the
last 24 hours, positivity for RVFV infection, number of persons living under the same roof, recent travel
outside the study site, highest education of the participant, and RVFV infection and seropositivity in goats,
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results are presented in Table 2. Results show that the male gender was signi cantly more related to RVFV
seropositivity (χ2 = 5.351; p = 0.030). Likewise, participants aged 50 years and above were more seropositive
as compared to their younger counterparts (χ2 = 14.430; p = 0.006). Bed net use, larger numbers of persons
living in the same house (> 7 persons), and RVFV seropositivity in goats were related to higher seropositivity
to RVFV (χ2 = 6.003; p = 0.021, χ2 = 23.213; p = 0.000 and 27.053; p = 0.000), respectively (Table 2). Among
the selected factors analyzed for possible association with IgM/IgG RVFV seropositivity in goats, only
IgM/IgG RVFV seropositivity in humans had a signi cant relationship (χ2 = 27.053; p = 0.000) (Table 3).
3.3 Comparison of mean IgM/IgG concentrations in humans and goats
When mean concentrations of antibodies to the RVF virus were compared between goats and humans, it
was observed that RVFV antibody concentrations were only marginally higher in humans without
statistically signi cant difference [t (112) = 0.526; p = 0.60)] (Table 4). Percentages of RVFV seropositive
humans and goats as well as PCR results for viral infections were determined (Fig. 2). Compared to humans,
goats were more seropositive to RVFV (23.3% seropositive goats against 13.2% seropositive humans).
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Table 2






Sex Male 47(71.2) 19 (28.8)  
  Female 90 (85.7) 15 (14.3) 5.351 (0.030)
Age Group 11–20 18 (94.7) 1 (5.3)  
  21–30 26 (92.9) 2 (7.1)  
  31–40 23 (88.5) 3 (11.5)  
  41–50 19 (82.6) 4 (17.4)  
  > 50 51 (67.1) 25 (32.9) 14.430 (0.006)
Human RVFV PCR Positive 0 (0) 7 (100)  
  Negative 1 (3.4) 28 (96.6) 0.248 (1.000)
Bed-Net Use Yes 24 (64.9) 13 (35.1)  
  No 110 (83.3) 22 (16.7) 6.003 (0.021)
Number of persons in a HH 1–3 45 (90) 5 (10)  
  4–6 74 (85.1) 13 (14.9)  
  7+ 17 (50) 17 (50) 23.213 (0.000)
Travel outside site Yes 48 (82.8) 10 (17.2)  
  No 89 (78.1) 25 (21.9) 0.521 (0.551)
Destination Urban 22 (88) 3 (12)  
  Peri-urban 10 (90.9) 1 (9.1)  
  Rural 16 (72.7) 6 (27.3) 2.545 (0.346)
Highest Education No Formal
Education
34 (81) 8 (19.8)  
  Primary 91 (78.4) 25 (21.6)  
  tertiary 12 (85.7) 2 (14.3) 0.465 (0.830)
RVFV Infection in goats Yes 1 (50) 8 (80)  
  No 1 (50) 2 (20) 0.800 (1.000)
RVFV seropositivity in
goats
Yes 11 (9.4) 24 (43.6)  
  No 106 (90.6) 31 (56.4) 27.053 (0.000)
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Table 3
Factors associated with RVFV seropositivity in goats
Variable Level Negative, n(%) Positive, n(%) χ2(p)
RVFV infection in goats Positive 3 (75.0) 8 (89.9)  
  Negative 1 (25.0) 1 (11.1) 0.410 (1.000)
Herd Size < 20 19 (39.6) 11 (39.3)  
  20–50 16 (33.3) 8 (28.6)  
  > 50 13 (27.1) 9 (32.1) 0.284 (0.913)
IgM/IgG seropositivity in Humans Positive 11 (9.4) 24 (43.6)  
  Negative 106 (90.6) 31 (56.4) 27.053 (0.000)
RVFRV infection in Humans Positive 2 (16.7) 5 (20.8)  
  Negative 10 (83.3) 19 (79.2) 0.089 (1.000)
Rvfv Rna Detection In Human, Goat, And Mosquito Samples
Aedes spp and Culex spp were the dominant species among collected mosquitoes. However, Mansonia spp
and Anopheles spp mosquitoes were also collected in smaller numbers. Our analyses were focused on
Aedes spp, Culex, spp as the main documented vectors for RVFV. When virus detection was performed using
polymerase chain reaction (RT-qPCR), goats exhibited the highest infection rate of 4.1%, followed by humans
(2.6%). Aedes spp had a higher infection rate of 2.3% compared to that of Culex spp which was recorded to
be 1.5%.
Table 4











95% CI of the Difference
Lower Upper
0.0363451 0.7346983 0.0691146 -0.1005966 0.173287 0.526 112 0.600
Discussion
The main aim of this study was to examine the degree of exposure to RVFV in goats and humans. This
study also sought to isolate RVFV in humans, goats, and key RVFV vector mosquitoes; Aedes spp and Culex
spp. Results from this study show that, although there has been no RVF outbreak reported in Tanzania since
2006–2007, antibodies to RVFV and the virus has been detected in humans and goats in Lower Moshi area.
Findings from this study indicate that13.2% and 23.3% of tested humans and goats had circulating
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antibodies to RVFV, respectively. Our  ndings emphasize an active exposure to RVFV during IEPs as
previously reported by some studies across geo-ecological zones of Tanzania [19, 25–28].
In this study, goats had higher exposure rates to RVFV compared to humans. Aedes spp, the major vector for
RVFV, is known to have bimodal daily feeding behavior with both exophagic and exophilic behaviors[29],
feeding on a wide range of mammalian hosts. Consequently, this behavior can be implicated as a key
behavior in its role as a vector for many zoonotic infections. Despite its preference for human hosts [29], we
report higher seropositivity in goats. The transmission of RVFV is not absolutely dependent on the presence
of vector mosquitoes. Direct human contact with infected animal tissues has been reported as a signi cant
factor for its transmission from animals to humans[30–32]. Not all of the human participants in this study
were directly involved in activities that bring them into direct contact with infected tissues such as infected
aborted fetuses and those working in slaughterhouses, which could partly explain the lower seropositivity to
RFVFV in humans compared to goats.
In the current study, RVFV RNA was detected in humans, goats, and mosquitoes. Goats exhibited the highest
infection rate of 4.1%, followed by humans (2.6%). Viral RNA was also detected in 2.3% and 1.5% of tested
Aedes spp and Culex spp mosquito pools. This study was conducted to shed light on the maintenance
mechanisms of RVFV by investigating both exposure and infection rates in mammalian and arthropod
vectors. To our knowledge, this is the  rst study conducted in Tanzania to concomitantly report on RVFV
diagnosis in humans, animals, and mosquitoes. Many of the previous studies that sought to understand the
epidemiology of RVFV in Tanzania, either focused on sero-epidemiology or could not detect RVFV RNA in
mammalian and arthropod vectors. Although the interactions of arboviruses and their vectors are complex
and their epidemiology is poorly understood, our  ndings support the hypothesis that during IEPs, RVFV is
likely maintained by localized low-level transmission between mosquito vectors and mammalian hosts
without any noticeable clinical symptoms[15, 32–34]. Evidence for RVFV transmission during IEPs has
previously been reported among humans, livestock, and wild animals in Tanzania and elsewhere [1–4, 6, 19,
24–28, 33, 35–38]. Although goats were more seropositive to RVFV compared to humans, paired
comparison of mean anti-RVFV IgG/IgM concentrations revealed no difference that existed between humans
and goats.
Some factors were signi cantly associated with seropositivity to RVFV in humans including male gender,
living more than 4 persons in a household, being older than 50 years, not using an insecticide-treated bed-
net, and higher RVFV seropositivity in goats. RVFV seropositivity in Humans was consequently associated
with seropositivity in goats. Males, especially in agropastoral communities seem to be more active outdoors
for various subsistence activities including farming and grazing which bring them into frequent contact with
RVFV susceptible or infected animals. This  nding stresses the need for continued distribution, access, and
usage of LLINs, especially among rural and agro-pastoral communities that are more prone to zoonotic
diseases.
The study site is characterized by features that are supportive of vector mosquito breeding and intimate
human-animal interaction. In the absence of reports on RVFV infection in areas nearby the study area, [19]
the detection of antibodies to RVFV in humans and goats and detection of RVFV in humans, goats, and
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mosquitoes in the study area suggests the site to be a potential RVF hotspot. The dominant pastoral grazing
system in the study area and surrounding areas is manifested as unlimited movements of livestock as a
result of environmental degradation of the wetland due to overstocking and overgrazing increases chances
for introducing the disease into new areas. The absence of clinical manifestations among livestock and
humans in the study area, which could be a consequence of herd immunity, seems to have escaped the
knowledge of the veterinary and public health authorities, raising concerns about the available local and
national capacity for preparedness and response machinery against zoonotic infectious with potential to
cause fatal epidemics. Thus, there exists a critical need for improved surveillance of RVF transmission
through detection of RVFV activity among humans, livestock, and vector mosquitoes.
Since passive surveillance of RVF is challenging in the absence of clinical features among humans and
livestock, active surveillance is recommended and, where resources may be limited, targeted surveillance in
high-risk areas (hot spots) will help prevent future RVF outbreaks. It is critically important to relook the
national contingency plans used in RVF surveillance and response to RVF outbreaks, bearing in mind that
observed active transmission of the virus occurs in the absence of expected clinical manifestations that
have been the traditional RVF pointers for a long time such as massive abortions in livestock.
Conclusion
Here, we present data that reveals the detection of anti-RVFV antibodies in humans and goats and isolation
of RVFV from humans, goats, and mosquitoes in an area with the necessary features for mosquito breeding.
Collected during a dry season of IEP, our data suggests the Lower Moshi area as a potential hotspot for RVF,
posing the danger of being a source of RVFV to other areas. Strategies for effective active surveillance of
RVF that involve the identi cation of RVF hotspots for targeted control are recommended.
List Of Abbreviations
RVF: Rift Valley Fever; RVFV: Rift Valley Fever Virus; IgG: Immunoglobulin G; IgM: Immunoglobulin M; IEP:
Inter epidemic Period; cELISA: competitive ELISA;RT-qPCR: Real Time quantitative Polymerase Chain
Reaction; RNA: Ribonucleic acid.
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